Intranasal co-administration with the mouse zona pellucida 3 expressing construct and its coding protein induces contraception in mice. (Q48682733)

14 February 2018

title

Intranasal co-administration with the mouse zona pellucida 3 expressing construct and its coding protein induces contraception in mice. (English)

1 reference

14 February 2018

1 reference

Ailian Zhang

1

1 reference

14 February 2018

Jinyao Li

2

1 reference

14 February 2018

Gan Zhao

3

1 reference

14 February 2018

Shuang Geng

4

1 reference

14 February 2018

Shuzhen Zhuang

5

1 reference

14 February 2018

Bin Wang

6

1 reference

14 February 2018

Fuchun Zhang

7

1 reference

14 February 2018

language of work or name

English

0 references

publication date

22 January 2011

1 reference

14 February 2018

number of pages

8

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

14 February 2018

volume

29

1 reference

14 February 2018

issue

39

1 reference

14 February 2018

page(s)

6785-6792

1 reference

14 February 2018

The potential of the zona pellucida as a target for immunocontraception

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.061

Antibodies to human ZP3 induce reversible contraception in transgenic mice with 'humanized' zonae pellucidae.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.061

Structure and function of the zona pellucida: identification and characterization of the proteins of the mouse oocyte's zona pellucida

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.061

Mammalian sperm-egg interaction: identification of a glycoprotein in mouse egg zonae pellucidae possessing receptor activity for sperm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.061

Towards molecular mechanisms for gamete adhesion and fusion during mammalian fertilization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.061

Analysis of the contraceptive potential of antibodies against native and deglycosylated porcine ZP3 in vivo and in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.061

Evaluation of the contraceptive potential of recombinant human ZP3 and human ZP3 peptides in a primate model: their safety and efficacy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.061

Evaluation of the immunocontraceptive potential of Escherichia coli-expressed recombinant dog ZP2 and ZP3 in a homologous animal model.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.061

Contraceptive responses of mice immunized with purified recombinant mouse zona pellucida subunit 3 (mZP3) proteins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.061

Construction of the plasmid pCMV4-rZPC' DNA vaccine and analysis of its contraceptive potential.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.061

Contraception in mice immunized with recombinant zona pellucida subunit 3 proteins correlates with Th2 responses and the levels of interleukin 4 expressed by CD4+ cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.061

Infertility in mice induced by a recombinant ectromelia virus expressing mouse zona pellucida glycoprotein 3.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.061

Immunocontraception is induced in BALB/c mice inoculated with murine cytomegalovirus expressing mouse zona pellucida 3.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.061

Contraceptive potential of synthetic peptides of zona pellucida protein (ZPA).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.061

Native zona pellucida reactivity and in-vitro effect on human sperm-egg binding with antisera against bonnet monkey ZP1 and ZP3 synthetic peptides.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.061

Impact of feline zona pellucida glycoprotein B-derived synthetic peptides on in vitro fertilization of cat oocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.061

Enhanced contraceptive response by co-immunization of DNA and protein vaccines encoding the mouse zona pellucida 3 with minimal oophoritis in mouse ovary.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.061

Nasal delivery of chitosan-DNA plasmid expressing epitopes of respiratory syncytial virus (RSV) induces protective CTL responses in BALB/c mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.061

Chitosan as a novel nasal delivery system for vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.061

Interleukin-15 enhance DNA vaccine elicited mucosal and systemic immunity against foot and mouth disease virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.061

Direct effect of bile salts and phospholipids on the physical properties of mucus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.061

Recovery of airway cystic fibrosis transmembrane conductance regulator function in mice with cystic fibrosis after single-dose lentivirus-mediated gene transfer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.061

Lysophosphatidylcholine enhances cytokine-induced interferon gamma expression in human T lymphocytes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.061

Lysophosphatidylcholine is a natural adjuvant that initiates cellular immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.061

Chitosan and depolymerized chitosan oligomers as condensing carriers for in vivo plasmid delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.061

The adjuvant effects of co-stimulatory molecules on cellular and memory responses to HBsAg DNA vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.061

Role of J chain and secretory component in receptor-mediated glandular and hepatic transport of immunoglobulins in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.061

Prospects of zona pellucida glycoproteins as immunogens for contraceptive vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.061

Human sperm-specific peptide vaccine that causes long-term reversible contraception.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.061

Autoimmune disease of the ovary induced by a ZP3 peptide from the mouse zona pellucida

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.061

Treatment of autoimmune ovarian disease by co-administration with mouse zona pellucida protein 3 and DNA vaccine through induction of adaptive regulatory T cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.061

Vaccination with a synthetic zona pellucida peptide produces long-term contraception in female mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.12.061

10.1016/J.VACCINE.2010.12.061

7 January 2021

Identifiers

DOI

1 reference

14 February 2018

PubMed ID

21262188

1 reference

14 February 2018